Biotech companies are looking for ways to speed up drug discovery and pharmaceutical companies need an easier way to find accurate drug pricing information to make their businesses more competitive. So two big data analytics companies graduating from Blueprint Health’s accelerator have taken a cue from Maverick and Goose. One offers a way to shrink the amount of time genome analysis takes and another developed a way to make it easier for drug companies to find global drug price data in real time.
{iframe}http://medcitynews.com/2014/10/big-data-analytics-mean-biotech-faster-genome-analysis-realtime-drug-price-data/{/iframe}